Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Merck, Seagen Takeover Talks Heat Up - WSJ

Published 06/24/2022, 03:09 AM
Updated 06/24/2022, 07:17 AM
© Reuters.  Merck (MRK), Seagen (SGEN) Takeover Talks Heat Up - WSJ

© Reuters. Merck (MRK), Seagen (SGEN) Takeover Talks Heat Up - WSJ

By Investing.com Staff

Takeover talks between Merck (NYSE:MRK) and Seagen (NASDAQ:SGEN) have accelerated and the two sides are scheduled to meet this week, the Wall Street Journal reported citing people familiar with the matter.

Last week, the Journal originally reported that Merck was in talks to acquire Seagen and others suitors may also be looking.

While the report added that it is unclear if Merck submitted a formal offer, Wall Street analysts have pegged a price of $200+ per share needed to get a deal done.

The two companies already have existing collaborations and Oppenheimer analyst Jay Olson recently noted that Merck and other large biopharma face patent cliffs that could be filled with a deal for Seagen. Olson pointed to Seagen's expertise in ADCs, which have increasing roles in the future oncology treatment paradigm. This, he said, was exemplified by the overwhelming efficacy of Seagen's Enhertu at ASCO2022.

Shares of Seagen gained 4% in pre-open trading Friday to $180 per share.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.